Tumor targeting with a99mTc-labeled AS1411 aptamer in prostate tumor cells

Internalization and subcellular fate of aptamer and peptide dual-functioned nanoparticles

(2014) Huile Gao et al.   JOURNAL OF DRUG TARGETING

Study and evaluation of mechanisms of dual targeting drug delivery system with tumor microenvironment assays compared with normal assays

(2013) Huile Gao et al.   Acta Biomaterialia

A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma

(2013) Jonathan E. Rosenberg et al.   INVESTIGATIONAL NEW DRUGS

An improved radiolabelled RNA aptamer molecule for HER2 imaging in cancers

(2013) Kambiz Varmira et al.   JOURNAL OF DRUG TARGETING

A HER2-targeted RNA aptamer molecule labeled with 99mTc for single-photon imaging in malignant tumors

(2013) Kambiz Varmira et al.   NUCLEAR MEDICINE AND BIOLOGY

Aptamer imaging with Cu-64 labeled AS1411: Preliminary assessment in lung cancer

(2013) Junling Li et al.   NUCLEAR MEDICINE AND BIOLOGY

In vivo uses of aptamers selected against cell surface biomarkers for therapy and molecular imaging

(2012) Agnes Cibiel et al.   BIOCHIMIE

Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles

(2012) Huile Gao et al.   BIOMATERIALS

Liver uptake of radiolabeled targeting proteins and peptides: considerations for targeting peptide conjugate design

(2012) Seyed Jalal Hosseinimehr et al.   DRUG DISCOVERY TODAY

Association of Symptomatic Benign Prostatic Hyperplasia and Prostate Cancer: Results from the Prostate Cancer Prevention Trial

(2011) J. M. Schenk et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Nucleic Acid Aptamers: Clinical Applications and Promising New Horizons

(2011) X. Ni et al.   CURRENT MEDICINAL CHEMISTRY

Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer

(2009) Paula J. Bates et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

A Nucleolin-Targeted Multimodal Nanoparticle Imaging Probe for Tracking Cancer Cells Using an Aptamer

(2009) D. W. Hwang et al.   JOURNAL OF NUCLEAR MEDICINE

The Nucleolin Targeting Aptamer AS1411 Destabilizes Bcl-2 Messenger RNA in Human Breast Cancer Cells

(2008) S. Soundararajan et al.   CANCER RESEARCH